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Summary: Trim33 (Tif1c, ectodermin, moonshine), a
member of the TIF1 family of transcriptional coactiva-
tors and corepressors, is a large nuclear protein that
contains an N-terminal tripartite (Trim) domain com-
posed of a RING domain, two B-box domains, and a
coiled coil domain. It has been suggested that Trim33
(Ectodermin) mediates ectodermal induction in the Xen-
opus by functioning as a Smad4 ubiquitin ligase, while in
the zebrafish Trim33 (moonshine) has been reported to
act as a R-Smad binding protein in induction of erythroid
differentiation. Since the developmental role of Trim33 in
mammals is currently unknown, we generated mice car-
rying the conditional Trim33 (Trim33FX) allele by flanking
exons 2–4 encoding most of the functionally critical N-
terminal tripartite domain by loxP sites. We confirmed
the null genotype by using the EIIa-Cre transgenic
approach to create mice that lack exons 2–4. Embryos
deficient in Trim33 die during early somitogenesis, dem-
onstrating that Trim33 plays an important nonredundant
role in mammalian embryonic development. genesis
46:329–333, 2008. VC 2008 Wiley-Liss, Inc.
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Trim33 (Tif1g) is one of 70 tripartite motif-containing
Trim proteins (Yan et al., 2004). Together with Trim24
(Tif1a) and Trim28 (Tif1b), it forms a transcription inter-
mediary factor-1 (Tif-1) subfamily of transcriptional
regulators (Venturini et al., 1999). Although Tif-1 pro-
teins all share several characteristic functional domains,
for example, amino terminal Trim domains, carboxy ter-
minal PHD finger, and Bromo domains, it is thought that
their biological functions are quite divergent. For
instance, Trim28, but neither Trim24 nor Trim33, has
been shown to interact with members of the KRAB zinc
finger proteins (Friedman et al., 1996; Kim et al., 1996).
Moreover, Trim28 is an intrinsic component of the his-
tone deacetylase N-CoR1/HDAC3 complex (Underhill
et al., 2000), whereas Trim24 does not bind nuclear hor-
mone receptors, but it has been shown to function as a
coactivator of the retinoid acid receptor (Fraser et al.,
1998). Whereas mouse embryos deficient in Trim28 die
soon after implantation, Trim24 is not essential for
embryogenesis, but was found to be a potent liver-spe-
cific tumor suppressor (Cammas et al., 2000; Khetchou-
mian et al., 2007). Much less is known about the biologi-
cal role of Trim33, particularly in mammals. This is
largely because of the fact that knockout mice have not
yet been developed. However, it was recently shown
that in Xenopus Trim33 functions as an E3 ubiquitin-
protein ligase promoting Smad4 degradation via the
ubiquitin proteasome pathway (Dupont et al., 2005).
In the zebrafish, Trim33 was shown to be required for
erythroid lineage-specific control of hematopoietic gene
expression (Ransom et al., 2004). Subsequently, it was
shown that R-Smad/Trim33 interaction is required for
Tgf-b-dependent erythroid differentiation. Interestingly,
it seems that in this context Trim33 does not target
Smad4 for degradation, but rather competes with it by
binding activated R-Smads (He et al., 2006).
To address the role of Trim33 in mammalian embryo-
genesis, we generated mice harboring the conditional
knockout allele for Trim33. Our strategy was to flank
exons 2–4 encoding the functionally critical RING and
B1 and B2 Box domains by loxP sites. The short (1.6 kb)
and long (8.2 kb) arms of the targeting vector were PCR
amplified from a Bac genomic DNA. The loxPNeoloxP
cassette was inserted into intron 1 and a single loxP site
was inserted into intron 4 (see Fig. 1). As a negative
selection marker we used the diphtheria toxin (DT)
gene. The linearized targeting vector was electroporated
into TVB2 embryonic stem cells as described (Yang and
Kaartinen, 2007). Fifteen out of 261 G418-resistant colo-
nies were targeted to the correct locus; however, only
three of them contained the 30 loxP site. All three cor-
rectly targeted ES clones were able to produce highly
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chimeric male mice, which in turn were potent germ
line transmitters. To remove the Neo selection marker
and to generate a presumed knockout allele for Trim33,
we crossed the Trim33FXNeo/FXNeo mice (homozygotes
for the targeting vector) with EIIa-Cre transgenic mice
(Xu et al., 2001). In these mice, Cre is expressed under
the control of the adenoviral EIIa promoter that targets
expression of the Cre recombinase to the early mouse
embryo (Lakso et al., 1996). The EIIa-Cre transgene cre-
ates both partial and complete recombinations and
FIG. 1. Trim33 targeting vector and
screening of ES colonies. A: A sche-
matic presentation of the Trim33 pro-
tein domains, Trim33 genomic locus
depicting a segment from exon1 to
intron 4, the Trim33 targeting vector
and the Trim33 targeted allele. B: An
example of a PCR screen (upper
panel); positive clones #102 and #113
can be easily identified. PCR analysis
using c/d primers and template DNA
from clones that suggested the cor-
rect targeting demonstrated that only
clones number #40, #119, and #259
(not shown) had retained the 30 loxP
site (lower panel). The wild type allele
produces a 713-bp amplification
product. Since the strategy to insert
the 30 loxP site into intron 4 involved
the replacement of a 553-bp SacI-
PstI fragment with a loxP site, the mu-
tant allele gives rise only to a 265-bp
amplification product.
FIG. 2. Generation of mice carry-
ing the floxed (Trim33FX) and
knockout (Trim33KO) Trim33 al-
leles. Transgenic EIIa-Cre mice
were crossed with mice homozy-
gous for the targeting vector. The
obtained mosaic males were
further crossed with wild-type
females to obtain Trim33FX/WT
mice (type I recombination; red
arrow) and Trim33KO/WT mice (type
II recombination; blue arrows).
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therefore EIIa-Cre transgenic mice can be used both as
a deleter mouse to generate knockout alleles and to
remove selection markers (e.g., loxP-pGKNeo-loxP)
when a triple loxP-strategy is used (Holzenberger et al.,
2000; Xu et al., 2001). The obtained mosaic male mice
progeny were subsequently crossed with wild-type
female mice to obtain the floxed (Trim33FX) and null
(Trim33KO) alleles (see Fig. 2). Homozygote Trim33FXFX
mice were viable and fertile, and they did not display
any recognizable phenotypes.
To confirm that the Trim33KO allele encoded the true
null allele and to provide initial information about the bi-
ological role of Trim33 during embryogenesis, we inter-
crossed the heterozygote Trim33KO/WT mice to obtain
homozygote Trim33KO/KO mice (Fig 3A). Genotype anal-
yses of newborn offspring revealed that all the homozy-
gote mutant pups died during gestation (Table 1). To
examine the time frame during which embryonic lethal-
ity occurred, we harvested embryos at different time
points and discovered that at E9 the mutant embryos dis-
played a dramatic developmental delay when compared
with controls (Table 1 and Fig. 3H–J). Nevertheless, they
had formed a body axis, displayed head folds and the
neural tube, and showed 5–6 somite pairs. We were
unable to discover any living mutant embryos after E9.5.
At E8.0–8.5 (3–6 somite pairs in controls), the Trim33
mutant embryos were aligned at the base of the yolk sac,
and while they had formed the anterior–posterior body
axis and identifiable anterior structures, for example,
head folds (arrows in Fig. 3D, E, and G), it was difficult
to identify any other embryonal structures. RT-PCR using
primers with target sequences in exons 4 and 7 did not
produce any detectable amplification product, while
the heterozygote and wild-type samples showed the
expected 423-bp fragment (Fig. 3B). This is concordant
with the lack of sequences encoded by exon 4. To fur-
ther validate the Trim33KO/KO allele, we used exon 1-
and exon 6-specific primers. The wild-type and homozy-
gote Trim33KO/KO alleles produced the expected 733-bp
and 366-bp products, respectively, while the heterozy-
gote samples gave rise to both PCR fragments (Fig. 3B).
RT-PCR analysis using primers specific for 30 exons 15
and 20 produced the expected 684-bp fragment from
wildtype, heterozygote (Trim33KO/WT) and homozygote
(Trim33KO/KO) samples suggesting that the mutated al-
lele lacking exons 2–4 is able to produce a stable mRNA
(Fig. 3B). To conclude, our RT-PCR analyses demon-
strated that the mRNA encoded by Trim33KO/KO allele
FIG. 3. Development of embryos deficient in Trim33 is arrested at
the early somitogenic stage. A: PCR genotyping of embryos from
the crossing between Trim33KO/WT males and females at E8.5. HE,
heterozyggotes; WT, wildtype; HO, homozygotes. B: RT-PCR analy-
sis of embryos harvested at E8.5 using primers for exons 4 and 7
demonstrates that Trim33KO/KO embryos do not display any detect-
able mRNA product, while wild-type and heterozygote controls
show an expected 423-bp PCR product (B, upper panel). Corre-
sponding analysis using primers for exons 1 and 6 show that the
wild-type sample produces the expected 733-bp PCR product, the
homozygote mutant sample produces the expected 336-bp prod-
uct, while the heterozygote samples gives rise to both 733-bp and
336-bp products (second panel from the top). Corresponding analy-
sis using primers for exons 15 and 20 shows that both the wild-type
and mutant alleles produce a 684-bp amplification product (second
panel from bottom). b-actin specific primers produced a 245-bp
amplification product with comparable intensity from all samples
(bottom panel). At E8.2–8.5, Trim33 null mutants (D, E, G) demon-
strate retarded development when compared to controls (C, F). D
and E depict both lateral and frontal images of the same embryo,
respectively. I: Development of the Trim33 2/2 embryos is arrested
at the early somitogenic stage (E9.0). J: A high power picture of a
Trim33 2/2 embryo shown in (I). H: Control littermate. Arrows in C,
D, E, G, and J point to head folds, white arrowhead in E points to
the primitive streak, and black arrowhead in J points to the somites.
Table 1




pairs Trim332/2 Trim331/2 Wild-type
Postnatal 0 12 2
E9.5 1 8 0
E9.0 2 4 4
E8.25–E8.5 5–6 6 4 2
E8.0 3 4 7 4
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lacks sequences encoded by exons 2–4, and that it is
highly likely that the phenotype observed in homozy-
gote samples results from a loss of Trim33 function, par-
ticularly since most of the possible splicings, for exam-
ple, exon 1 to 4, will lead to a frameshift and premature
translational stop. These mutant mRNAs would produce
only the very N-terminal peptide encoded by Trim33
exon 1. Only the splicing from exon 1 to 9 or exon 1 to
13 would maintain the open reading frame. In these
unlikely hypothetical cases the protein product would
lack the tripartite motif, but would contain the C-termi-
nal PHD and Bromo domains. Based on the current
knowledge, it is impossible to say whether these aber-
rant proteins lacking the functionally important tripar-
tite motif would posses any biological activity.
A recent publication of Dupont et al. showed that in
Xenopus embryos XTrim33 (Ectodermin) plays a criti-
cal role in controlling TGF-b responses during gastrula-
tion (Dupont et al., 2005). Specifically, these authors
demonstrated that XTrim33 is required for specification
of the ectoderm and for restricting the mesoderm-induc-
ing activity of TGF-bs. Our finding that Trim33 null
embryos die during somitogenesis demonstrates that
Trim33 is also required for early embryogenesis in mam-
mals. If the role of Trim33 is to negatively regulate Tgf-b
signaling during embryogenesis, one would expect that
Trim33 null mutants would display phenotypes that are
consistent with amplified Tgf-b signaling. The observed
external Trim33KO/KO phenotype is very similar to that
seen in transgenic mouse embryos that demonstrate ec-
topic expression of the Tgf-b type II receptor (Zwijsen
et al., 1999). Another study recently demonstrated that
abrogation of Drap1, a negative regulator of Nodal, leads
to aberrant Nodal signaling and early embryonic lethality
(Iratni et al., 2002). Interestingly, similar to Trim33KOKO
mutants, embryos that are heterozygous for Nodal and
lack Drap1 undergo gastrulation, but die at E9.5. Subse-
quent studies will show whether the observed pheno-
type results from defects in ectodermal spefication or
some other catastrophic mechanistic failure during early
embryogenesis. Moreover, mice carrying the floxed
Trim33 allele (Trim33FX) as described herein can be
used to investigate the role of this gene later in develop-
ment during organogenesis, as well as during postnatal
life.
METHODS
Generation of Mice Carrying the Floxed and
Knockout Trim33 Alleles
RP2468C16 Bac DNA was used as a template to PCR
amplify both short and long arms as ClaI-XhoI and
KpnI-SalI fragments, respectively. High-fidelity Supermix
(Qiagen, Valencia, CA) polymerase was used for amplifi-
cation, and the generated arms were sequenced to verify
that no PCR-generated mutations were introduced. A sin-
gle loxP site was inserted into intron 4 by replacing a
small 553-bp SacI-PstI fragment with a loxP sequence
flanked by SacI and PstI restriction sites. Subsequently, a
loxPNeoloxP cassette was inserted as a XhoI-NotI frag-
ment into the pKODT plasmid. A long arm containing
the single loxP sequence in intron 4 was inserted as a
KpnI-SalI fragment into loxPNeoloxP/pKODT, and finally
a short arm was added into the construct as a ClaI-XhoI
fragment. The targeting vector was electroporated into
TVB2 mouse ES cells, and recombinant ES cell clones
were selected with G418 as described (Kaartinen et al.,
2004, 1995). Mouse chimeras were generated by inject-
ing correctly targeted ES clones into C57BL/6J mouse
blastocysts. The floxed Trim33 allele (Trim33FX) and
the knockout Trim33 allele (Trim33KO) were generated
by crossing female mice homozygous for the targeting
vector with EIIa-Cre transgenic male mice (Xu et al.,
2001), which were obtained from Jackson Laboratories
(Bar Harbor, ME).
PCR Screening, Clone Verification, and Genotyping
ES cell DNAs were first screened for correct targeting
by PCR using a forward primer (a0) 50 CACGACACAAA-
GAACTGTAG 30 and a reverse primer (b0) 50 CAAG-
CAAAACCAAATTAAGG 30. Subsequently, the presence
of the single loxP site in intron 4 was verified by PCR
using a forward primer (c) 50 CATTGTGCTT-
CACCTCCTCCTCTTCG 30 and a reverse primer (d) 50
GGGAGGGAAAATCTGGCTGAA 30. Trim33FX mice were
genotyped using forward and reverse primers (a) 50
GCACCTTGATGAGATCTTCCTCCTCC 30 and (b) 50 GAC-
GACATACTGGACACCGTA 30, respectively, while
Trim33KO mice were genotyped using forward and
reverse primers (a) 50 GCACCTTGATGAGATCTTCCT
CCTCC 30 and (d) 50 GGAGGGAAAATCTGGCTGAA 30,
respectively.
Timed Matings and Embryos Analyses
Mice were mated during the dark period of the con-
trolled light cycle. Female mice acquiring vaginal plugs
were designated as day 0. At the time interval indicated
in respective figures (E8 to E9), females were euthanized
by CO2 and embryos were extracted in PBS (Invitrogen)
followed by further analyses. All studies and procedures
performed on mice were carried out at the Animal Care
Facility of the Saban Research Institute and were
approved by the CHLA Animal Care and Use Committee
(IACUC). The mice were maintained in mixed genetic
backgrounds.
RT-PCR
Total RNA was isolated from E8 embryos using the
RNeasy mini kit (Qiagen), and cDNAs were synthesized
by the Omniscript reverse transcription kit (Qiagen)
according to the manufacturers’ protocols. Subse-
quently, the cDNAs were analyzed by PCR for Trim33
expression using the following primer pairs. b-actin was
used as a quality and loading control.
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